speb/financial-data huggingface dataset:
CFFI balance_sheet (quarterly, 2026-03-31) — Receivables: 11752000.00
CFFI income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 940000.00
CFFI cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -10000000.00
CFFI cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -614000.00
CFFI balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 273883000.00
CFFI income_statement (quarterly, 2026-03-31) — Salaries And Wages: 14158000.00
CFFI cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 14590000.00
CFFI income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 547000.00
CFFI income_statement (quarterly, 2026-03-31) — Selling General And Administration: 15135000.00
CFFI balance_sheet (quarterly, 2026-03-31) — Share Issued: 3248149.00
CFFI cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -10000000.00
CFFI cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 514000.00
CFFI balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 265470000.00
CFFI balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 239395000.00
CFFI income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CFFI income_statement (quarterly, 2026-03-31) — Tax Provision: 1550000.00
CFFI income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.19
CFFI balance_sheet (quarterly, 2026-03-31) — Total Assets: 2813748000.00
CFFI balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 348721000.00
CFFI balance_sheet (quarterly, 2026-03-31) — Total Debt: 103251000.00
CFFI balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 266112000.00
CFFI balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2547636000.00
CFFI income_statement (quarterly, 2026-06-30) — Basic Average Shares: 3252163.00
CFFI income_statement (quarterly, 2026-06-30) — Basic EPS: 2.63
CFFI income_statement (quarterly, 2026-06-30) — Diluted Average Shares: 3252163.00
CFFI income_statement (quarterly, 2026-06-30) — Diluted EPS: 2.63
CFFN balance_sheet (annual, 2021-09-30) — Accounts Payable: 129270000.00
CFFN cash_flow (annual, 2021-09-30) — Change In Account Payable: -14306000.00
CFFN cash_flow (annual, 2021-09-30) — Change In Other Working Capital: 105000.00
CFFN cash_flow (annual, 2021-09-30) — Change In Payable: -14306000.00
CFFN cash_flow (annual, 2021-09-30) — Change In Payables And Accrued Expense: -14306000.00
CFFN balance_sheet (annual, 2021-09-30) — Income Tax Payable: 918000.00
CFFN balance_sheet (annual, 2021-09-30) — Non Current Deferred Liabilities: 5810000.00
CFFN balance_sheet (annual, 2021-09-30) — Non Current Deferred Taxes Liabilities: 5810000.00
CFFN income_statement (annual, 2021-09-30) — Other Gand A: 17922000.00
CFFN income_statement (annual, 2021-09-30) — Other Special Charges: 4752000.00
CFFN balance_sheet (annual, 2021-09-30) — Payables: 918000.00
CFFN balance_sheet (annual, 2021-09-30) — Payables And Accrued Expenses: 918000.00
CFFN cash_flow (annual, 2021-09-30) — Proceeds From Stock Option Exercised: 324000.00
CFFN income_statement (annual, 2021-09-30) — Special Income Charges: -4752000.00
CFFN balance_sheet (annual, 2021-09-30) — Total Tax Payable: 918000.00
CFFN income_statement (annual, 2021-09-30) — Total Unusual Items: -4752000.00
CFFN income_statement (annual, 2021-09-30) — Total Unusual Items Excluding Goodwill: -4752000.00
CFFN income_statement (annual, 2022-09-30) — +Total Revenue: 212627000.00
CFFN balance_sheet (annual, 2022-09-30) — Accumulated Depreciation: -93393000.00
CFFN balance_sheet (annual, 2022-09-30) — Additional Paid In Capital: 1190213000.00
CFFN cash_flow (annual, 2022-09-30) — Amortization Cash Flow: 1372000.00
CFFN cash_flow (annual, 2022-09-30) — Amortization Of Intangibles: 1372000.00
CFFN income_statement (annual, 2022-09-30) — Basic Average Shares: 136214516.00
CFFN income_statement (annual, 2022-09-30) — Basic EPS: 0.62
CFFN cash_flow (annual, 2022-09-30) — Beginning Cash Position: 70292000.00
CFFN balance_sheet (annual, 2022-09-30) — Buildings And Improvements: 122196000.00
CFFN cash_flow (annual, 2022-09-30) — Capital Expenditure: -5557000.00
CFFN balance_sheet (annual, 2022-09-30) — Capital Stock: 1388000.00
CFFN balance_sheet (annual, 2022-09-30) — Cash And Cash Equivalents: 49194000.00
CFFN balance_sheet (annual, 2022-09-30) — Cash Cash Equivalents And Federal Funds Sold: 49194000.00
CFFN cash_flow (annual, 2022-09-30) — Cash Dividends Paid: -103131000.00
CFFN cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Financing Activities: 49177000.00
CFFN cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Investing Activities: -167576000.00
CFFN cash_flow (annual, 2022-09-30) — Cash Flow From Continuing Operating Activities: 97301000.00
CFFN cash_flow (annual, 2022-09-30) — Change In Other Current Assets: 18711000.00
CFFN cash_flow (annual, 2022-09-30) — Change In Other Current Liabilities: -10823000.00
CFFN cash_flow (annual, 2022-09-30) — Change In Other Working Capital: -2197000.00
CFFN cash_flow (annual, 2022-09-30) — Change In Receivables: -2197000.00
CFFN cash_flow (annual, 2022-09-30) — Change In Working Capital: 5691000.00
CFFN cash_flow (annual, 2022-09-30) — Changes In Cash: -21098000.00
CFFN balance_sheet (annual, 2022-09-30) — Common Stock: 1388000.00
CFFN cash_flow (annual, 2022-09-30) — Common Stock Dividend Paid: -103131000.00
CFFN balance_sheet (annual, 2022-09-30) — Common Stock Equity: 1096499000.00
CFFN cash_flow (annual, 2022-09-30) — Common Stock Payments: 0.00
CFFN cash_flow (annual, 2022-09-30) — Deferred Income Tax: 2047000.00
CFFN cash_flow (annual, 2022-09-30) — Deferred Tax: 2047000.00
CFFN cash_flow (annual, 2022-09-30) — Depreciation: 9365000.00
CFFN cash_flow (annual, 2022-09-30) — Depreciation Amortization Depletion: 10737000.00
CFFN cash_flow (annual, 2022-09-30) — Depreciation And Amortization: 10737000.00
CFFN income_statement (annual, 2022-09-30) — Diluted Average Shares: 136214516.00
CFFN income_statement (annual, 2022-09-30) — Diluted EPS: 0.62
CFFN income_statement (annual, 2022-09-30) — Diluted NI Availto Com Stockholders: 84408000.00
CFFN cash_flow (annual, 2022-09-30) — End Cash Position: 49194000.00
CFFN cash_flow (annual, 2022-09-30) — Financing Cash Flow: 49177000.00
CFFN cash_flow (annual, 2022-09-30) — Free Cash Flow: 91744000.00
CFFN cash_flow (annual, 2022-09-30) — Gain Loss On Investment Securities: 0.00
CFFN income_statement (annual, 2022-09-30) — Gain On Sale Of Security: 0.00
CFFN balance_sheet (annual, 2022-09-30) — Gains Losses Not Affecting Retained Earnings: -145633000.00
CFFN income_statement (annual, 2022-09-30) — General And Administrative Expense: 59620000.00
CFFN balance_sheet (annual, 2022-09-30) — Gross PPE: 188213000.00
CFFN cash_flow (annual, 2022-09-30) — Income Tax Paid Supplemental Data: 13559000.00
CFFN balance_sheet (annual, 2022-09-30) — Income Tax Payable: 0.00
CFFN income_statement (annual, 2022-09-30) — Insurance And Claims: 3020000.00
CFFN income_statement (annual, 2022-09-30) — Interest Expense: 86946000.00
CFFN income_statement (annual, 2022-09-30) — Interest Income: 279540000.00
CFFN cash_flow (annual, 2022-09-30) — Interest Paid Supplemental Data: 83833000.00
CFFN balance_sheet (annual, 2022-09-30) — Invested Capital: 3228653000.00
CFFN cash_flow (annual, 2022-09-30) — Investing Cash Flow: -167576000.00
CFFN balance_sheet (annual, 2022-09-30) — Investments And Advances: 1563307000.00
CFFN cash_flow (annual, 2022-09-30) — Issuance Of Debt: 1454402000.00
CFFN balance_sheet (annual, 2022-09-30) — Land And Improvements: 16222000.00
CFFN balance_sheet (annual, 2022-09-30) — Long Term Debt: 2132154000.00
CFFN balance_sheet (annual, 2022-09-30) — Long Term Debt And Capital Lease Obligation: 2132154000.00
CFFN cash_flow (annual, 2022-09-30) — Long Term Debt Issuance: 1454402000.00
CFFN cash_flow (annual, 2022-09-30) — Long Term Debt Payments: -906902000.00
CFFN balance_sheet (annual, 2022-09-30) — Machinery Furniture Equipment: 49795000.00
CFFN cash_flow (annual, 2022-09-30) — Net Common Stock Issuance: 0.00
CFFN balance_sheet (annual, 2022-09-30) — Net Debt: 2082960000.00
CFFN income_statement (annual, 2022-09-30) — Net Income: 84453000.00
CFFN income_statement (annual, 2022-09-30) — Net Income Common Stockholders: 84408000.00
CFFN income_statement (annual, 2022-09-30) — Net Income Continuous Operations: 84453000.00
CFFN income_statement (annual, 2022-09-30) — Net Income From Continuing And Discontinued Operation: 84453000.00
CFFN income_statement (annual, 2022-09-30) — Net Income From Continuing Operation Net Minority Interest: 84453000.00
CFFN cash_flow (annual, 2022-09-30) — Net Income From Continuing Operations: 84453000.00
CFFN income_statement (annual, 2022-09-30) — Net Income Including Noncontrolling Interests: 84453000.00
CFFN income_statement (annual, 2022-09-30) — Net Interest Income: 192594000.00
CFFN cash_flow (annual, 2022-09-30) — Net Investment Purchase And Sale: 234999000.00
CFFN cash_flow (annual, 2022-09-30) — Net Issuance Payments Of Debt: 547500000.00
CFFN cash_flow (annual, 2022-09-30) — Net Long Term Debt Issuance: 547500000.00
CFFN cash_flow (annual, 2022-09-30) — Net Other Financing Charges: 7338000.00
CFFN cash_flow (annual, 2022-09-30) — Net Other Investing Changes: -15457000.00
CFFN balance_sheet (annual, 2022-09-30) — Net PPE: 94820000.00
CFFN cash_flow (annual, 2022-09-30) — Net PPE Purchase And Sale: -5557000.00
CFFN balance_sheet (annual, 2022-09-30) — Net Tangible Assets: 1096499000.00
CFFN income_statement (annual, 2022-09-30) — Normalized Income: 84453000.00
CFFN income_statement (annual, 2022-09-30) — Occupancy And Equipment: 14370000.00
CFFN cash_flow (annual, 2022-09-30) — Operating Cash Flow: 97301000.00
CFFN cash_flow (annual, 2022-09-30) — Operating Gains Losses: -10031000.00
CFFN income_statement (annual, 2022-09-30) — Operating Revenue: 212627000.00
CFFN balance_sheet (annual, 2022-09-30) — Ordinary Shares Number: 135885320.00
CFFN balance_sheet (annual, 2022-09-30) — Other Equity Adjustments: -145633000.00
CFFN balance_sheet (annual, 2022-09-30) — Other Equity Interest: -29735000.00
CFFN income_statement (annual, 2022-09-30) — Other Gand A: 18311000.00
CFFN cash_flow (annual, 2022-09-30) — Other Non Cash Items: 25000.00
CFFN income_statement (annual, 2022-09-30) — Other Non Interest Expense: 30886000.00
CFFN balance_sheet (annual, 2022-09-30) — Other Receivables: 1266000.00
CFFN balance_sheet (annual, 2022-09-30) — Other Short Term Investments: 1563307000.00
CFFN income_statement (annual, 2022-09-30) — Otherunder Preferred Stock Dividend: 45000.00
CFFN balance_sheet (annual, 2022-09-30) — Payables: 0.00
CFFN balance_sheet (annual, 2022-09-30) — Payables And Accrued Expenses: 0.00
CFFN balance_sheet (annual, 2022-09-30) — Preferred Stock: 0.00
CFFN income_statement (annual, 2022-09-30) — Pretax Income: 107203000.00
CFFN cash_flow (annual, 2022-09-30) — Proceeds From Stock Option Exercised: 0.00
CFFN cash_flow (annual, 2022-09-30) — Purchase Of Investment: -88026000.00
CFFN cash_flow (annual, 2022-09-30) — Purchase Of PPE: -5557000.00
CFFN balance_sheet (annual, 2022-09-30) — Receivables: 1266000.00
CFFN income_statement (annual, 2022-09-30) — Reconciled Depreciation: 10737000.00
CFFN cash_flow (annual, 2022-09-30) — Repayment Of Debt: -906902000.00
CFFN cash_flow (annual, 2022-09-30) — Repurchase Of Capital Stock: 0.00
CFFN balance_sheet (annual, 2022-09-30) — Retained Earnings: 80266000.00
CFFN income_statement (annual, 2022-09-30) — Salaries And Wages: 56600000.00
CFFN cash_flow (annual, 2022-09-30) — Sale Of Investment: 323025000.00
CFFN income_statement (annual, 2022-09-30) — Selling And Marketing Expense: 5178000.00
CFFN income_statement (annual, 2022-09-30) — Selling General And Administration: 64798000.00
CFFN balance_sheet (annual, 2022-09-30) — Share Issued: 138858884.00
CFFN cash_flow (annual, 2022-09-30) — Stock Based Compensation: 2238000.00
CFFN balance_sheet (annual, 2022-09-30) — Stockholders Equity: 1096499000.00
CFFN balance_sheet (annual, 2022-09-30) — Tangible Book Value: 1096499000.00
CFFN income_statement (annual, 2022-09-30) — Tax Effect Of Unusual Items: 0.00
CFFN income_statement (annual, 2022-09-30) — Tax Provision: 22750000.00
CFFN income_statement (annual, 2022-09-30) — Tax Rate For Calcs: 0.21
CFFN balance_sheet (annual, 2022-09-30) — Total Assets: 9624897000.00
CFFN balance_sheet (annual, 2022-09-30) — Total Capitalization: 3228653000.00
CFFN balance_sheet (annual, 2022-09-30) — Total Debt: 2132154000.00
CFFN balance_sheet (annual, 2022-09-30) — Total Equity Gross Minority Interest: 1096499000.00
CFFN balance_sheet (annual, 2022-09-30) — Total Liabilities Net Minority Interest: 8528398000.00
CFFN balance_sheet (annual, 2022-09-30) — Total Tax Payable: 0.00
CFFN balance_sheet (annual, 2022-09-30) — Treasury Shares Number: 2973564.00
CFFN income_statement (annual, 2023-09-30) — +Total Revenue: -20877000.00
CFFN balance_sheet (annual, 2023-09-30) — Accumulated Depreciation: -100708000.00
CFFN balance_sheet (annual, 2023-09-30) — Additional Paid In Capital: 1166643000.00
CFFN cash_flow (annual, 2023-09-30) — Amortization Cash Flow: 1069000.00
CFFN cash_flow (annual, 2023-09-30) — Amortization Of Intangibles: 1069000.00
CFFN income_statement (annual, 2023-09-30) — Basic Average Shares: 133128009.00
CFFN income_statement (annual, 2023-09-30) — Basic EPS: -0.84
CFFN cash_flow (annual, 2023-09-30) — Beginning Cash Position: 49194000.00
CFFN balance_sheet (annual, 2023-09-30) — Buildings And Improvements: 123830000.00
CFFN cash_flow (annual, 2023-09-30) — Capital Expenditure: -6281000.00
CFFN balance_sheet (annual, 2023-09-30) — Capital Stock: 1359000.00
CFFN balance_sheet (annual, 2023-09-30) — Cash And Cash Equivalents: 245605000.00
CFFN balance_sheet (annual, 2023-09-30) — Cash Cash Equivalents And Federal Funds Sold: 245605000.00
CFFN cash_flow (annual, 2023-09-30) — Cash Dividends Paid: -83172000.00
CFFN balance_sheet (annual, 2023-09-30) — Cash Financial: 31775000.00
CFFN cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Financing Activities: 477983000.00
CFFN cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Investing Activities: -329103000.00
CFFN cash_flow (annual, 2023-09-30) — Cash Flow From Continuing Operating Activities: 47531000.00
CFFN cash_flow (annual, 2023-09-30) — Change In Other Current Assets: 4468000.00
CFFN cash_flow (annual, 2023-09-30) — Change In Other Current Liabilities: -4372000.00
CFFN cash_flow (annual, 2023-09-30) — Change In Other Working Capital: -7303000.00
CFFN cash_flow (annual, 2023-09-30) — Change In Receivables: -7303000.00
CFFN cash_flow (annual, 2023-09-30) — Change In Working Capital: -7207000.00
CFFN cash_flow (annual, 2023-09-30) — Changes In Cash: 196411000.00
CFFN balance_sheet (annual, 2023-09-30) — Common Stock: 1359000.00
CFFN cash_flow (annual, 2023-09-30) — Common Stock Dividend Paid: -83172000.00
CFFN balance_sheet (annual, 2023-09-30) — Common Stock Equity: 1044054000.00
CFFN cash_flow (annual, 2023-09-30) — Common Stock Payments: -23453000.00
CFFN cash_flow (annual, 2023-09-30) — Deferred Income Tax: -45520000.00
CFFN cash_flow (annual, 2023-09-30) — Deferred Tax: -45520000.00
CFFN cash_flow (annual, 2023-09-30) — Depreciation: 9039000.00
CFFN cash_flow (annual, 2023-09-30) — Depreciation Amortization Depletion: 10108000.00
CFFN cash_flow (annual, 2023-09-30) — Depreciation And Amortization: 10108000.00
CFFN income_statement (annual, 2023-09-30) — Diluted Average Shares: 133128009.00
CFFN income_statement (annual, 2023-09-30) — Diluted EPS: -0.84
CFFN income_statement (annual, 2023-09-30) — Diluted NI Availto Com Stockholders: -101608000.00
CFFN cash_flow (annual, 2023-09-30) — End Cash Position: 245605000.00
CFFN cash_flow (annual, 2023-09-30) — Financing Cash Flow: 477983000.00
CFFN cash_flow (annual, 2023-09-30) — Free Cash Flow: 41250000.00
CFFN cash_flow (annual, 2023-09-30) — Gain Loss On Investment Securities: 192622000.00
CFFN income_statement (annual, 2023-09-30) — Gain On Sale Of Security: -192622000.00
CFFN balance_sheet (annual, 2023-09-30) — Gains Losses Not Affecting Retained Earnings: 8700000.00
CFFN income_statement (annual, 2023-09-30) — General And Administrative Expense: 55947000.00
CFFN balance_sheet (annual, 2023-09-30) — Gross PPE: 192239000.00
CFFN cash_flow (annual, 2023-09-30) — Income Tax Paid Supplemental Data: 5424000.00
CFFN income_statement (annual, 2023-09-30) — Insurance And Claims: 4456000.00
CFFN income_statement (annual, 2023-09-30) — Interest Expense: 206517000.00
CFFN income_statement (annual, 2023-09-30) — Interest Income: 359789000.00
CFFN cash_flow (annual, 2023-09-30) — Interest Paid Supplemental Data: 188908000.00
CFFN balance_sheet (annual, 2023-09-30) — Invested Capital: 3423179000.00
CFFN cash_flow (annual, 2023-09-30) — Investing Cash Flow: -329103000.00
CFFN balance_sheet (annual, 2023-09-30) — Investments And Advances: 1384482000.00
CFFN cash_flow (annual, 2023-09-30) — Issuance Of Debt: 4293870000.00
CFFN balance_sheet (annual, 2023-09-30) — Land And Improvements: 16045000.00
CFFN balance_sheet (annual, 2023-09-30) — Long Term Debt: 2379125000.00
CFFN balance_sheet (annual, 2023-09-30) — Long Term Debt And Capital Lease Obligation: 2379125000.00
CFFN cash_flow (annual, 2023-09-30) — Long Term Debt Issuance: 4293870000.00
CFFN cash_flow (annual, 2023-09-30) — Long Term Debt Payments: -3548542000.00
CFFN balance_sheet (annual, 2023-09-30) — Machinery Furniture Equipment: 52364000.00
CFFN cash_flow (annual, 2023-09-30) — Net Common Stock Issuance: -23453000.00
CFFN balance_sheet (annual, 2023-09-30) — Net Debt: 2133520000.00
CFFN income_statement (annual, 2023-09-30) — Net Income: -101659000.00
CFFN income_statement (annual, 2023-09-30) — Net Income Common Stockholders: -101608000.00
CFFN income_statement (annual, 2023-09-30) — Net Income Continuous Operations: -101659000.00
CFFN income_statement (annual, 2023-09-30) — Net Income From Continuing And Discontinued Operation: -101659000.00
CFFN income_statement (annual, 2023-09-30) — Net Income From Continuing Operation Net Minority Interest: -101659000.00
CFFN cash_flow (annual, 2023-09-30) — Net Income From Continuing Operations: -101659000.00
CFFN income_statement (annual, 2023-09-30) — Net Income Including Noncontrolling Interests: -101659000.00
CFFN income_statement (annual, 2023-09-30) — Net Interest Income: 153272000.00
CFFN cash_flow (annual, 2023-09-30) — Net Investment Purchase And Sale: 186860000.00
CFFN cash_flow (annual, 2023-09-30) — Net Issuance Payments Of Debt: 745328000.00
CFFN cash_flow (annual, 2023-09-30) — Net Long Term Debt Issuance: 745328000.00
CFFN cash_flow (annual, 2023-09-30) — Net Other Financing Charges: -17074000.00
CFFN cash_flow (annual, 2023-09-30) — Net Other Investing Changes: 4984000.00
CFFN balance_sheet (annual, 2023-09-30) — Net PPE: 91531000.00
CFFN cash_flow (annual, 2023-09-30) — Net PPE Purchase And Sale: -6281000.00
CFFN balance_sheet (annual, 2023-09-30) — Net Tangible Assets: 1044054000.00
CFFN income_statement (annual, 2023-09-30) — Normalized Income: -101659000.00
CFFN income_statement (annual, 2023-09-30) — Occupancy And Equipment: 14236000.00
CFFN cash_flow (annual, 2023-09-30) — Operating Cash Flow: 47531000.00
CFFN cash_flow (annual, 2023-09-30) — Operating Gains Losses: 178801000.00
CFFN income_statement (annual, 2023-09-30) — Operating Revenue: -20877000.00
CFFN balance_sheet (annual, 2023-09-30) — Ordinary Shares Number: 133128009.00
CFFN balance_sheet (annual, 2023-09-30) — Other Equity Adjustments: 8700000.00
CFFN balance_sheet (annual, 2023-09-30) — Other Equity Interest: -28083000.00
CFFN cash_flow (annual, 2023-09-30) — Other Non Cash Items: 5000.00
CFFN income_statement (annual, 2023-09-30) — Other Non Interest Expense: 36752000.00
CFFN balance_sheet (annual, 2023-09-30) — Other Receivables: 8531000.00
CFFN balance_sheet (annual, 2023-09-30) — Other Short Term Investments: 1384482000.00
CFFN income_statement (annual, 2023-09-30) — Otherunder Preferred Stock Dividend: -51000.00
CFFN balance_sheet (annual, 2023-09-30) — Preferred Stock: 0.00
CFFN income_statement (annual, 2023-09-30) — Pretax Income: -138955000.00
CFFN cash_flow (annual, 2023-09-30) — Proceeds From Stock Option Exercised: 0.00
CFFN cash_flow (annual, 2023-09-30) — Purchase Of Investment: 0.00
CFFN cash_flow (annual, 2023-09-30) — Purchase Of PPE: -6281000.00
CFFN balance_sheet (annual, 2023-09-30) — Receivables: 8531000.00
CFFN income_statement (annual, 2023-09-30) — Reconciled Depreciation: 10108000.00
CFFN cash_flow (annual, 2023-09-30) — Repayment Of Debt: -3548542000.00
CFFN cash_flow (annual, 2023-09-30) — Repurchase Of Capital Stock: -23453000.00
CFFN balance_sheet (annual, 2023-09-30) — Retained Earnings: -104565000.00
CFFN income_statement (annual, 2023-09-30) — Salaries And Wages: 51491000.00
CFFN cash_flow (annual, 2023-09-30) — Sale Of Investment: 186860000.00
CFFN cash_flow (annual, 2023-09-30) — Sale Of PPE: 0.00
CFFN income_statement (annual, 2023-09-30) — Selling And Marketing Expense: 4305000.00
CFFN income_statement (annual, 2023-09-30) — Selling General And Administration: 60252000.00
CFFN balance_sheet (annual, 2023-09-30) — Share Issued: 135936375.00
CFFN cash_flow (annual, 2023-09-30) — Stock Based Compensation: 1506000.00
CFFN balance_sheet (annual, 2023-09-30) — Stockholders Equity: 1044054000.00
CFFN balance_sheet (annual, 2023-09-30) — Tangible Book Value: 1044054000.00
CFFN income_statement (annual, 2023-09-30) — Tax Effect Of Unusual Items: 0.00
CFFN income_statement (annual, 2023-09-30) — Tax Provision: -37296000.00
CFFN income_statement (annual, 2023-09-30) — Tax Rate For Calcs: 0.27
CFFN balance_sheet (annual, 2023-09-30) — Total Assets: 10177461000.00
CFFN balance_sheet (annual, 2023-09-30) — Total Capitalization: 3423179000.00
CFFN balance_sheet (annual, 2023-09-30) — Total Debt: 2379125000.00
CFFN balance_sheet (annual, 2023-09-30) — Total Equity Gross Minority Interest: 1044054000.00
CFFN balance_sheet (annual, 2023-09-30) — Total Liabilities Net Minority Interest: 9133407000.00
CFFN balance_sheet (annual, 2023-09-30) — Treasury Shares Number: 2808366.00
CFFN income_statement (annual, 2024-09-30) — +Total Revenue: 164586000.00
CFFN balance_sheet (annual, 2024-09-30) — Accumulated Depreciation: -107822000.00
CFFN balance_sheet (quarterly, 2024-09-30) — Accumulated Depreciation: -107822000.00
CFFN balance_sheet (annual, 2024-09-30) — Additional Paid In Capital: 1146851000.00
CFFN cash_flow (annual, 2024-09-30) — Amortization Cash Flow: 774000.00
CFFN cash_flow (annual, 2024-09-30) — Amortization Of Intangibles: 774000.00
CFFN income_statement (annual, 2024-09-30) — Basic Average Shares: 130092397.00
CFFN income_statement (annual, 2024-09-30) — Basic EPS: 0.29
CFFN cash_flow (annual, 2024-09-30) — Beginning Cash Position: 245605000.00
CFFN balance_sheet (annual, 2024-09-30) — Buildings And Improvements: 128730000.00
CFFN balance_sheet (quarterly, 2024-09-30) — Buildings And Improvements: 128730000.00
CFFN cash_flow (annual, 2024-09-30) — Capital Expenditure: -7184000.00
CFFN balance_sheet (annual, 2024-09-30) — Capital Lease Obligations: 1081000.00
CFFN balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 1081000.00
CFFN balance_sheet (annual, 2024-09-30) — Capital Stock: 1327000.00
CFFN balance_sheet (annual, 2024-09-30) — Cash And Cash Equivalents: 217307000.00
CFFN balance_sheet (annual, 2024-09-30) — Cash Cash Equivalents And Federal Funds Sold: 217307000.00
CFFN cash_flow (annual, 2024-09-30) — Cash Dividends Paid: -44522000.00
CFFN balance_sheet (annual, 2024-09-30) — Cash Financial: 25169000.00
CFFN cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Financing Activities: -688591000.00
CFFN cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Investing Activities: 629109000.00
CFFN cash_flow (annual, 2024-09-30) — Cash Flow From Continuing Operating Activities: 31184000.00
CFFN cash_flow (annual, 2024-09-30) — Change In Other Current Assets: -3623000.00
CFFN cash_flow (annual, 2024-09-30) — Change In Other Current Liabilities: -22831000.00
CFFN cash_flow (annual, 2024-09-30) — Change In Receivables: 8139000.00
CFFN cash_flow (annual, 2024-09-30) — Change In Working Capital: -18315000.00
CFFN cash_flow (annual, 2024-09-30) — Changes In Cash: -28298000.00
CFFN balance_sheet (annual, 2024-09-30) — Common Stock: 1327000.00
CFFN cash_flow (annual, 2024-09-30) — Common Stock Dividend Paid: -44522000.00
CFFN balance_sheet (annual, 2024-09-30) — Common Stock Equity: 1032270000.00
CFFN cash_flow (annual, 2024-09-30) — Common Stock Payments: -19448000.00
CFFN cash_flow (annual, 2024-09-30) — Deferred Income Tax: 3546000.00
CFFN cash_flow (annual, 2024-09-30) — Deferred Tax: 3546000.00
CFFN cash_flow (annual, 2024-09-30) — Depreciation: 7929000.00
CFFN cash_flow (annual, 2024-09-30) — Depreciation Amortization Depletion: 8703000.00
CFFN cash_flow (annual, 2024-09-30) — Depreciation And Amortization: 8703000.00
CFFN income_statement (annual, 2024-09-30) — Diluted Average Shares: 130092397.00
CFFN income_statement (annual, 2024-09-30) — Diluted EPS: 0.29
CFFN income_statement (annual, 2024-09-30) — Diluted NI Availto Com Stockholders: 37977000.00
CFFN cash_flow (annual, 2024-09-30) — End Cash Position: 217307000.00
CFFN cash_flow (annual, 2024-09-30) — Financing Cash Flow: -688591000.00
CFFN cash_flow (annual, 2024-09-30) — Free Cash Flow: 24000000.00
CFFN cash_flow (annual, 2024-09-30) — Gain Loss On Investment Securities: 13345000.00
CFFN cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: 0.00
CFFN income_statement (annual, 2024-09-30) — Gain On Sale Of Security: -13345000.00
CFFN income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: 0.00
CFFN balance_sheet (annual, 2024-09-30) — Gains Losses Not Affecting Retained Earnings: 21627000.00
CFFN income_statement (annual, 2024-09-30) — General And Administrative Expense: 58324000.00
CFFN balance_sheet (annual, 2024-09-30) — Gross PPE: 199285000.00
CFFN balance_sheet (quarterly, 2024-09-30) — Gross PPE: 199285000.00
CFFN cash_flow (annual, 2024-09-30) — Income Tax Paid Supplemental Data: 6017000.00
CFFN income_statement (annual, 2024-09-30) — Insurance And Claims: 6052000.00
CFFN income_statement (annual, 2024-09-30) — Interest Expense: 214782000.00
CFFN income_statement (annual, 2024-09-30) — Interest Income: 376843000.00
CFFN cash_flow (annual, 2024-09-30) — Interest Paid Supplemental Data: 224701000.00
CFFN balance_sheet (annual, 2024-09-30) — Invested Capital: 3210753000.00
CFFN cash_flow (annual, 2024-09-30) — Investing Cash Flow: 629109000.00
CFFN balance_sheet (annual, 2024-09-30) — Investments And Advances: 856266000.00
CFFN cash_flow (annual, 2024-09-30) — Issuance Of Debt: 350100000.00
CFFN balance_sheet (annual, 2024-09-30) — Land And Improvements: 16070000.00
CFFN balance_sheet (quarterly, 2024-09-30) — Land And Improvements: 16070000.00
CFFN balance_sheet (annual, 2024-09-30) — Long Term Capital Lease Obligation: 1081000.00
CFFN balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 1081000.00
CFFN balance_sheet (annual, 2024-09-30) — Long Term Debt: 2178483000.00
CFFN balance_sheet (annual, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 2179564000.00
CFFN cash_flow (annual, 2024-09-30) — Long Term Debt Issuance: 350100000.00
CFFN cash_flow (annual, 2024-09-30) — Long Term Debt Payments: -1052291000.00
CFFN balance_sheet (annual, 2024-09-30) — Machinery Furniture Equipment: 54485000.00
CFFN balance_sheet (quarterly, 2024-09-30) — Machinery Furniture Equipment: 54485000.00
CFFN cash_flow (annual, 2024-09-30) — Net Common Stock Issuance: -19448000.00
CFFN balance_sheet (annual, 2024-09-30) — Net Debt: 1961176000.00
CFFN income_statement (annual, 2024-09-30) — Net Income: 38010000.00
CFFN income_statement (annual, 2024-09-30) — Net Income Common Stockholders: 37977000.00
CFFN income_statement (annual, 2024-09-30) — Net Income Continuous Operations: 38010000.00
CFFN income_statement (annual, 2024-09-30) — Net Income From Continuing And Discontinued Operation: 38010000.00
CFFN income_statement (annual, 2024-09-30) — Net Income From Continuing Operation Net Minority Interest: 38010000.00
CFFN cash_flow (annual, 2024-09-30) — Net Income From Continuing Operations: 38010000.00
CFFN income_statement (annual, 2024-09-30) — Net Income Including Noncontrolling Interests: 38010000.00
CFFN income_statement (annual, 2024-09-30) — Net Interest Income: 162061000.00
CFFN cash_flow (annual, 2024-09-30) — Net Investment Purchase And Sale: 550977000.00
CFFN cash_flow (annual, 2024-09-30) — Net Issuance Payments Of Debt: -702191000.00
CFFN cash_flow (annual, 2024-09-30) — Net Long Term Debt Issuance: -702191000.00
CFFN cash_flow (annual, 2024-09-30) — Net Other Financing Charges: -1192000.00
CFFN cash_flow (annual, 2024-09-30) — Net Other Investing Changes: 21690000.00
CFFN balance_sheet (annual, 2024-09-30) — Net PPE: 91463000.00
CFFN cash_flow (annual, 2024-09-30) — Net PPE Purchase And Sale: -7184000.00
CFFN balance_sheet (annual, 2024-09-30) — Net Tangible Assets: 1032270000.00
CFFN income_statement (annual, 2024-09-30) — Normalized Income: 38010000.00
CFFN income_statement (annual, 2024-09-30) — Occupancy And Equipment: 13558000.00
CFFN cash_flow (annual, 2024-09-30) — Operating Cash Flow: 31184000.00
CFFN cash_flow (annual, 2024-09-30) — Operating Gains Losses: 3336000.00
CFFN income_statement (annual, 2024-09-30) — Operating Revenue: 164586000.00
CFFN balance_sheet (annual, 2024-09-30) — Ordinary Shares Number: 130092397.00
CFFN balance_sheet (annual, 2024-09-30) — Other Equity Adjustments: 21627000.00
CFFN balance_sheet (annual, 2024-09-30) — Other Equity Interest: -26431000.00
CFFN cash_flow (annual, 2024-09-30) — Other Non Cash Items: 13000.00
CFFN cash_flow (quarterly, 2024-09-30) — Other Non Cash Items: 7000.00
CFFN income_statement (annual, 2024-09-30) — Other Non Interest Expense: 33078000.00
CFFN balance_sheet (annual, 2024-09-30) — Other Receivables: 359000.00
CFFN balance_sheet (annual, 2024-09-30) — Other Short Term Investments: 856266000.00
CFFN income_statement (annual, 2024-09-30) — Otherunder Preferred Stock Dividend: 33000.00
CFFN balance_sheet (annual, 2024-09-30) — Preferred Stock: 0.00
CFFN income_statement (annual, 2024-09-30) — Pretax Income: 54103000.00
CFFN cash_flow (annual, 2024-09-30) — Purchase Of Investment: -1176645000.00
CFFN cash_flow (annual, 2024-09-30) — Purchase Of PPE: -7184000.00
CFFN balance_sheet (annual, 2024-09-30) — Receivables: 359000.00
CFFN income_statement (annual, 2024-09-30) — Reconciled Depreciation: 8703000.00
CFFN cash_flow (annual, 2024-09-30) — Repayment Of Debt: -1052291000.00
CFFN cash_flow (annual, 2024-09-30) — Repurchase Of Capital Stock: -19448000.00
CFFN balance_sheet (annual, 2024-09-30) — Retained Earnings: -111104000.00
CFFN income_statement (annual, 2024-09-30) — Salaries And Wages: 52272000.00
CFFN cash_flow (annual, 2024-09-30) — Sale Of Investment: 1727622000.00
CFFN cash_flow (annual, 2024-09-30) — Sale Of PPE: 0.00
CFFN income_statement (annual, 2024-09-30) — Selling And Marketing Expense: 4264000.00
CFFN income_statement (annual, 2024-09-30) — Selling General And Administration: 62588000.00
CFFN balance_sheet (annual, 2024-09-30) — Share Issued: 132735565.00
CFFN cash_flow (annual, 2024-09-30) — Stock Based Compensation: 1285000.00
CFFN balance_sheet (annual, 2024-09-30) — Stockholders Equity: 1032270000.00
CFFN balance_sheet (annual, 2024-09-30) — Tangible Book Value: 1032270000.00
CFFN income_statement (annual, 2024-09-30) — Tax Effect Of Unusual Items: 0.00
CFFN income_statement (annual, 2024-09-30) — Tax Provision: 16093000.00
CFFN income_statement (annual, 2024-09-30) — Tax Rate For Calcs: 0.30
CFFN balance_sheet (annual, 2024-09-30) — Total Assets: 9527608000.00
CFFN balance_sheet (annual, 2024-09-30) — Total Capitalization: 3210753000.00
CFFN balance_sheet (annual, 2024-09-30) — Total Debt: 2179564000.00
CFFN balance_sheet (annual, 2024-09-30) — Total Equity Gross Minority Interest: 1032270000.00
CFFN balance_sheet (annual, 2024-09-30) — Total Liabilities Net Minority Interest: 8495338000.00
CFFN balance_sheet (annual, 2024-09-30) — Treasury Shares Number: 2643168.00
CFFN cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: 0.00
CFFN income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 0.00
CFFN balance_sheet (quarterly, 2024-12-31) — Other Receivables: 843000.00
CFFN income_statement (quarterly, 2025-03-31) — +Total Revenue: 47914000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 1146733000.00
CFFN cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 137000.00
CFFN cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 137000.00
CFFN income_statement (quarterly, 2025-03-31) — Basic Average Shares: 128325000.00
CFFN income_statement (quarterly, 2025-03-31) — Basic EPS: 0.12
CFFN cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 170324000.00
CFFN cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -756000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Capital Stock: 1328000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 340389000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Federal Funds Sold: 340389000.00
CFFN cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -11062000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Cash Financial: 16837000.00
CFFN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 162959000.00
CFFN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -8399000.00
CFFN cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 15505000.00
CFFN cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 4069000.00
CFFN cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -3705000.00
CFFN cash_flow (quarterly, 2025-03-31) — Change In Receivables: -558000.00
CFFN cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 614000.00
CFFN cash_flow (quarterly, 2025-03-31) — Changes In Cash: 170065000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Common Stock: 1328000.00
CFFN cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -11062000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1037110000.00
CFFN cash_flow (quarterly, 2025-03-31) — Common Stock Payments: 0.00
CFFN cash_flow (quarterly, 2025-03-31) — Depreciation: 1815000.00
CFFN cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 1952000.00
CFFN cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 1952000.00
CFFN income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 128325000.00
CFFN income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.12
CFFN income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 15381000.00
CFFN cash_flow (quarterly, 2025-03-31) — End Cash Position: 340389000.00
CFFN cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 162959000.00
CFFN cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 14749000.00
CFFN cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: 0.00
CFFN income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 0.00
CFFN balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 17052000.00
CFFN income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 16033000.00
CFFN income_statement (quarterly, 2025-03-31) — Insurance And Claims: 1095000.00
CFFN income_statement (quarterly, 2025-03-31) — Interest Expense: 54335000.00
CFFN income_statement (quarterly, 2025-03-31) — Interest Income: 98175000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Invested Capital: 3180066000.00
CFFN cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -8399000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Investments And Advances: 961417000.00
CFFN cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 150100000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 2142956000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 2142956000.00
CFFN cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 150100000.00
CFFN cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -171279000.00
CFFN cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CFFN balance_sheet (quarterly, 2025-03-31) — Net Debt: 1802567000.00
CFFN income_statement (quarterly, 2025-03-31) — Net Income: 15399000.00
CFFN income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 15381000.00
CFFN income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 15399000.00
CFFN income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 15399000.00
CFFN income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 15399000.00
CFFN cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 15399000.00
CFFN income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 15399000.00
CFFN income_statement (quarterly, 2025-03-31) — Net Interest Income: 43840000.00
CFFN cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -90229000.00
CFFN cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -21179000.00
CFFN cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -21179000.00
CFFN cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: 28772000.00
CFFN cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 3982000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Net PPE: 89081000.00
CFFN cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -713000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1037110000.00
CFFN income_statement (quarterly, 2025-03-31) — Normalized Income: 15399000.00
CFFN income_statement (quarterly, 2025-03-31) — Occupancy And Equipment: 3502000.00
CFFN cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 15505000.00
CFFN cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -2285000.00
CFFN income_statement (quarterly, 2025-03-31) — Operating Revenue: 47914000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 130069898.00
CFFN balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: 17052000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: -25606000.00
CFFN income_statement (quarterly, 2025-03-31) — Other Non Interest Expense: 8366000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Other Receivables: 1397000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 961417000.00
CFFN income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 18000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
CFFN income_statement (quarterly, 2025-03-31) — Pretax Income: 19253000.00
CFFN cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -138042000.00
CFFN cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -756000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Receivables: 1397000.00
CFFN income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 1952000.00
CFFN cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -171279000.00
CFFN cash_flow (quarterly, 2025-03-31) — Repurchase Of Capital Stock: 0.00
CFFN balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -102397000.00
CFFN income_statement (quarterly, 2025-03-31) — Salaries And Wages: 14938000.00
CFFN cash_flow (quarterly, 2025-03-31) — Sale Of Investment: 47813000.00
CFFN income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 760000.00
CFFN income_statement (quarterly, 2025-03-31) — Selling General And Administration: 16793000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Share Issued: 132786365.00
CFFN cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 344000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1037110000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1037110000.00
CFFN income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CFFN income_statement (quarterly, 2025-03-31) — Tax Provision: 3854000.00
CFFN income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.20
CFFN balance_sheet (quarterly, 2025-03-31) — Total Assets: 9718184000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 3180066000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Total Debt: 2142956000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1037110000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 8681074000.00
CFFN balance_sheet (quarterly, 2025-03-31) — Treasury Shares Number: 2716467.00
CFFN income_statement (quarterly, 2025-06-30) — +Total Revenue: 50031000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 1146648000.00
CFFN cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 137000.00
CFFN cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 137000.00
CFFN income_statement (quarterly, 2025-06-30) — Basic Average Shares: 130081000.00
CFFN income_statement (quarterly, 2025-06-30) — Basic EPS: 0.14
CFFN cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 340389000.00
CFFN cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -1642000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Capital Stock: 1328000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 174965000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Federal Funds Sold: 174965000.00
CFFN cash_flow (quarterly, 2025-06-30) — Cash Dividends Paid: -11063000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Cash Financial: 24413000.00
CFFN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -40200000.00
CFFN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -137628000.00
CFFN cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 12404000.00
CFFN cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: -2155000.00
CFFN cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: -5110000.00
CFFN cash_flow (quarterly, 2025-06-30) — Change In Receivables: 313000.00
CFFN cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -6929000.00
CFFN cash_flow (quarterly, 2025-06-30) — Changes In Cash: -165424000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Common Stock: 1328000.00
CFFN cash_flow (quarterly, 2025-06-30) — Common Stock Dividend Paid: -11063000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 1046158000.00
CFFN cash_flow (quarterly, 2025-06-30) — Common Stock Payments: 0.00
CFFN cash_flow (quarterly, 2025-06-30) — Depreciation: 1778000.00
CFFN cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 1915000.00
CFFN cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 1915000.00
CFFN income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 130081000.00
CFFN income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.14
CFFN income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 18360000.00
CFFN cash_flow (quarterly, 2025-06-30) — End Cash Position: 174965000.00
CFFN cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -40200000.00
CFFN cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 10762000.00
CFFN cash_flow (quarterly, 2025-06-30) — Gain Loss On Investment Securities: 0.00
CFFN income_statement (quarterly, 2025-06-30) — Gain On Sale Of Security: 0.00
CFFN balance_sheet (quarterly, 2025-06-30) — Gains Losses Not Affecting Retained Earnings: 18453000.00
CFFN income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 16349000.00
CFFN income_statement (quarterly, 2025-06-30) — Insurance And Claims: 1072000.00
CFFN income_statement (quarterly, 2025-06-30) — Interest Expense: 54220000.00
CFFN income_statement (quarterly, 2025-06-30) — Interest Income: 99678000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Invested Capital: 3117743000.00
CFFN cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -137628000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 956229000.00
CFFN cash_flow (quarterly, 2025-06-30) — Issuance Of Debt: 300000000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 2071585000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 2071585000.00
CFFN cash_flow (quarterly, 2025-06-30) — Long Term Debt Issuance: 300000000.00
CFFN cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -371179000.00
CFFN cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 0.00
CFFN balance_sheet (quarterly, 2025-06-30) — Net Debt: 1896620000.00
CFFN income_statement (quarterly, 2025-06-30) — Net Income: 18382000.00
CFFN income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 18360000.00
CFFN income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 18382000.00
CFFN income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 18382000.00
CFFN income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 18382000.00
CFFN cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 18382000.00
CFFN income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 18382000.00
CFFN income_statement (quarterly, 2025-06-30) — Net Interest Income: 45458000.00
CFFN cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 9054000.00
CFFN cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -71179000.00
CFFN cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -71179000.00
CFFN cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: -16550000.00
CFFN cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 3306000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Net PPE: 88967000.00
CFFN cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -1642000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 1046158000.00
CFFN income_statement (quarterly, 2025-06-30) — Normalized Income: 18382000.00
CFFN income_statement (quarterly, 2025-06-30) — Occupancy And Equipment: 3270000.00
CFFN cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 12404000.00
CFFN cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: -2197000.00
CFFN income_statement (quarterly, 2025-06-30) — Operating Revenue: 50031000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 130257930.00
CFFN balance_sheet (quarterly, 2025-06-30) — Other Equity Adjustments: 18453000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Other Equity Interest: -25193000.00
CFFN cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 1712000.00
CFFN income_statement (quarterly, 2025-06-30) — Other Non Interest Expense: 7777000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Other Receivables: 1070000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 956229000.00
CFFN income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 22000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Preferred Stock: 0.00
CFFN income_statement (quarterly, 2025-06-30) — Pretax Income: 21633000.00
CFFN cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: -38749000.00
CFFN cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -1642000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Receivables: 1070000.00
CFFN income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 1915000.00
CFFN cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -371179000.00
CFFN cash_flow (quarterly, 2025-06-30) — Repurchase Of Capital Stock: 0.00
CFFN balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -95078000.00
CFFN income_statement (quarterly, 2025-06-30) — Salaries And Wages: 15277000.00
CFFN cash_flow (quarterly, 2025-06-30) — Sale Of Investment: 47803000.00
CFFN cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 0.00
CFFN income_statement (quarterly, 2025-06-30) — Selling And Marketing Expense: 1453000.00
CFFN income_statement (quarterly, 2025-06-30) — Selling General And Administration: 17802000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Share Issued: 132800865.00
CFFN cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 330000.00
CFFN balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 1046158000.00